136 related articles for article (PubMed ID: 28582347)
21. Cadherin expression in glandular tumors of the cervix.
Han AC; Edelson MI; Peralta Soler A; Knudsen KA; Lifschitz-Mercer B; Czernobilsky B; Rosenblum NG; Salazar H
Cancer; 2000 Nov; 89(10):2053-8. PubMed ID: 11066045
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
[TBL] [Abstract][Full Text] [Related]
23. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
24. Characteristic Cytological Findings of Lobular Endocervical Glandular Hyperplasia Associated with Adenocarcinoma of the Uterine Cervix.
Ishii S; Ito T; Yamada M; Yamazaki N; Ikebata K; Fujiyama J; Furuta N; Komatsu K; Takeuchi K; Sugiyama Y; Takazawa Y
Acta Cytol; 2020; 64(6):556-562. PubMed ID: 32814324
[TBL] [Abstract][Full Text] [Related]
25. Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.
Yamanoi K; Ishii K; Tsukamoto M; Asaka S; Nakayama J
Virchows Arch; 2018 Sep; 473(3):305-311. PubMed ID: 29845361
[TBL] [Abstract][Full Text] [Related]
26. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
27. SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinoma.
Hopman ANH; Moshi JM; Hoogduin KJ; Ummelen M; Henfling MER; van Engeland M; Wouters KAD; Stoop H; Looijenga LHJ; Ramaekers FCS
Histopathology; 2020 Feb; 76(3):383-393. PubMed ID: 31444787
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma of the Uterine Cervix: Immunohistochemical Biomarker Expression and Diagnostic Performance.
Duggan MA; Duan Q; Pfeiffer RM; Brett MA; Lee S; Köbel M; Sar A
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):209-217. PubMed ID: 33264105
[TBL] [Abstract][Full Text] [Related]
29. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
Shukla A; Thomas D; Roh MH
Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
[TBL] [Abstract][Full Text] [Related]
30. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Ling C; Shen Y
J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
[TBL] [Abstract][Full Text] [Related]
31. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry as a diagnostic aid in cervical pathology.
McCluggage WG
Pathology; 2007 Feb; 39(1):97-111. PubMed ID: 17365826
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions.
El-Ghobashy AA; Shaaban AM; Innes J; Prime W; Herrington CS
Eur J Cancer; 2007 Sep; 43(13):2011-8. PubMed ID: 17693084
[TBL] [Abstract][Full Text] [Related]
34. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervical-type mucinous adenocarcinoma of the uterine cervix.
Sasajima Y; Mikami Y; Kaku T; Kiyokawa T; Ohishi Y; Hamada T; Sasaki T; Fujita H; Moriya T; Kasamatsu T; Tsuda H
Histopathology; 2008 Oct; 53(4):487-90. PubMed ID: 18631191
[No Abstract] [Full Text] [Related]
35. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
[TBL] [Abstract][Full Text] [Related]
36. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.
Kawauchi S; Kusuda T; Liu XP; Suehiro Y; Kaku T; Mikami Y; Takeshita M; Nakao M; Chochi Y; Sasaki K
Am J Surg Pathol; 2008 Dec; 32(12):1807-15. PubMed ID: 18779726
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
38. Diffuse laminar endocervical glandular hyperplasia: a case report.
Dainty LA; Krivak TC; Webb JC; Zahn CM; Elkas JC; Chernofsky MR; Rose GS; Maxwell GL
Int J Gynecol Cancer; 2009 Aug; 19(6):1091-3. PubMed ID: 19820374
[TBL] [Abstract][Full Text] [Related]
39. Desmoplastic stromal response as defined by positive α-smooth muscle actin staining is predictive of invasion in adenocarcinoma of the uterine cervix.
Jordan SM; Watanabe T; Osann K; Monk BJ; Lin F; Rutgers JK
Int J Gynecol Pathol; 2012 Jul; 31(4):369-76. PubMed ID: 22653352
[TBL] [Abstract][Full Text] [Related]
40. Label-Free Quantitative Comparison of Cervical Mucus Peptides in Subjects With Endocervical Adenocarcinoma and Adenocarcinoma in Situ.
Shi F; Li X; Ma Z; Luan T; Zhong T; Gu Y
Technol Cancer Res Treat; 2021; 20():1533033821997825. PubMed ID: 33612089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]